Dong-A ST with Beactica to develop new cancer treatments

Dong-A ST Co., Ltd., a Korean pharmaceutical company, and Beactica Therapeutics AB, a Swedish drug discovery company, ha...

December 5, 2019 | Thursday | News
IDF reiterates global emergency of diabetes

International Diabetes Federation (IDF) has released the 9th edition of the IDF Diabetes Atlas at the recent IDF 2019 Co...

December 3, 2019 | Tuesday | News
Roche showcases innovations at IDF 2019 in Korea

At the International Diabetes Federation (IDF) Congress 2019 being held from 2 to 6 December 2019 in Busan, Korea, Swiss...

December 3, 2019 | Tuesday | News
Chugai to sell stake to JW Pharma for JV in Korea

Japanese firm Chugai Pharmaceutical Co., Ltd. and Korea based JW Pharmaceutical Corporation have agreed to cha...

December 2, 2019 | Monday | News
GeneMedicine, WuXi ATU to build oncolytic virus products

WuXi ATU Co., Ltd., a subsidiary of WuXi AppTec, and GeneMedicine - a South Korea-based gene therapy biotechnology ...

November 29, 2019 | Friday | Analysis
Korea to strengthen healthcare cooperation with ASEAN

Ministry of Health and Welfare in Korea is  accelerating efforts to build a Republic Of Korea (ROK)-ASEAN dialogue ...

November 27, 2019 | Wednesday | News
SK Biopharma’s Anti-Epileptic Drug gets FDA nod

Korea based SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and brin...

November 25, 2019 | Monday | News
ABL Bio inks strategic partnership with GenScript

China based GenScript Biologics, a world leading bio-pharmaceutical CDMO company, has announced that it has entered into...

November 20, 2019 | Wednesday | News
iHerb to expand in the Korean health and wellness market

iHerb announces a partnership with 11STREET to further expand its footprint in the Korean health and wellness market &nd...

November 18, 2019 | Monday | News
Samsung Biologics enhances its trusted service

South Korea based Samsung Biologics announced that it has obtained ISO 27001 certification, the most prestigious in...

November 15, 2019 | Friday | News
Yuhan Pharmaceuticals partners with Cyclica

South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology c...

November 13, 2019 | Wednesday | News
OSE Immunotherapeutics inks licensing deal with Chong Kun Dang Pharma

French biotech company OSE Immunotherapeutics has announced a new licensing deal with South Korea based Chong Kun D...

November 12, 2019 | Tuesday | News
Korea's 2019 Anti-Aging Expo in Changwon-si, Gyeongsangnam-do

The 2019 Anti-Aging Expo (AAGE2019), in relation to Gyeongsangnam-do's main business idea of 'The future 50 years of Gye...

November 11, 2019 | Monday | News
Samsung Bioepis teams up with Biogen for next-gen biosimilars

South Korea based Samsung Bioepis Co., Ltd. announced that it has entered into a new commercialization agreement with US...

November 8, 2019 | Friday | News
Janssen Korea announces winners for Innovation QuickFire Challenge in Smart Healthcare

Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and...

November 5, 2019 | Tuesday | News
Samsung Biologics collaborates with Ichnos Sciences in derma space

South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Scie...

November 6, 2019 | Wednesday | News
SNUBH achieves global healthcare accreditation

Seoul National University Bundang Hospital (SNUBH) in Seoul, South Korea has been awarded a thr...

November 5, 2019 | Tuesday | News
Korea reinforces national responsibility on dementia

The Ministry of Health and Welfare, Korea was part of the 2nd National Dementia Management Committee that was ...

November 4, 2019 | Monday | News
Korea focuses on international co-operation in healthcare

The Ministry of Health and Welfare, Korea announced that Minister Park Neung-hoo attended the G20 Health Ministers&rsquo...

October 28, 2019 | Monday | News
South Korea approves oral wound solution by Solasia

Japan based Solasia Pharma K.K., a specialty pharmaceutical company, has officially announced that episil® oral liqu...

October 22, 2019 | Tuesday | News
DongKoo inks agreement to market onychomycosis drug

Swedish firm Moberg Pharma AB has signed a distribution agreement with South Korea headquartered DongKoo Bio&n...

October 21, 2019 | Monday | News
GC Pharma, Vaxess team up for influenza vaccine smart release patch

South Korea headquartered GC Pharma, a leading manufacturer of influenza vaccines with a global reach, and US based Vaxe...

October 17, 2019 | Thursday | News
Celemics releases comprehensive NGS target enrichment workflow

South Korea based Celemics, provider of NGS target enrichment kits and innovative sequencing platforms, has announced th...

October 16, 2019 | Wednesday | News
Wontech receives FDA clearance for HairBoom Air

WONTECH, a leading Korean laser and energy based medical aesthetic device company announced that its LLLT hair loss trea...

October 14, 2019 | Monday | News
Korean lab develops cosmetics to improve skin acne

A research institute in South Korea has succeeded in developing cosmetics that can change the skin properties of people ...

October 8, 2019 | Tuesday | News
Biocept technology receives South Korean patent

Biocept, Inc., a US based  commercial provider of liquid biopsy tests designed to provide physicians with clin...

October 4, 2019 | Friday | News
Bukwang Pharma invests $5M in JV with Aslan

Singapore based ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, and Bukwang P...

October 3, 2019 | Thursday | News
Rafael Pharma expands Ph 3 trial of cancer drug candidate in South Korea

US based Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, has announ...

September 24, 2019 | Tuesday | News
CPhI Korea reports huge boom in Korean Pharma

The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders As...

September 20, 2019 | Friday | News
LIPAC, Huons ink licensing deal for bladder cancer drug candidate

LIPAC Oncology LLC and Huons Co., Ltd have announced that they have entered into an exclusive licensing agreement to dev...

September 18, 2019 | Wednesday | News
Novotech highlights South Korea's plans on clinical trials advancements

Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...

September 16, 2019 | Monday | News
Samsung Bioepis continues global expansion

Korean firm Samsung Bioepis Co., Ltd. has announced its expansion into the Brazilian biopharmaceutical market. The first...

September 11, 2019 | Wednesday | News
KT Corp unveils global epidemic prevention platform in Laos

KT Corp. said its Global Epidemic Prevention Platform (GEPP) began service in Lao PDR on September 6 to help t...

September 10, 2019 | Tuesday | News
Evidence found on Korean Ginseng's effects on improving bone health

The Korea Ginseng Association introduced new evidence of Korean Ginseng's efficacy on bone health. Korean Gins...

September 9, 2019 | Monday | News
Wontech's Holmium laser receives FDA approval

WONTECH, a leading Korean medical device company, has announced that its Holmium laser device, Holinwon Prima, received ...

September 9, 2019 | Monday | News
ITM, DCB sign agreement for Targeted Radionuclide Therapy

ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemB...

September 2, 2019 | Monday | News
Agilent Presents Thought Leader Award to Professor Hyun Joo An

-Agilent Technologies has announced that Professor Hyun Joo An has received an Agilent Thought Leader Award in support o...

August 29, 2019 | Thursday | News
Voronoi selects CDD Vault platform to manage Drug Discovery Data

Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...

August 23, 2019 | Friday | News
Gencurix's study explores GenesWell BCT and Oncotype DX differences

Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study on Frontiers in Oncology&...

August 23, 2019 | Friday | News
Sustainable manufacturing practices to combat growing AMR

Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institut...

August 20, 2019 | Tuesday | News
NOAC treatment effective against liver disease-associated atrial fibrillation

Researchers at Seoul National University Hospital have found that non-vitamin K oral anticoagulant (NOAC) is effective i...

August 20, 2019 | Tuesday | News
IDF Congress to bring together global diabetes community

The International Diabetes Federation (IDF) Congress is bringing together the global diabetes community to tackle a broa...

August 20, 2019 | Tuesday | News
KT Corp. unveils Global Epidemic Prevention Platform outside Korea

KT Corp. said its Global Epidemic Prevention Platform (GEPP) started service in Ghana on 14th, the first such ...

August 19, 2019 | Monday | News
Straumann Group to expand Warantec dental implants biz

Headquartered in Switzerland, The Straumann Group has entered into a partnership with Yuhan Corporation, Korea’s l...

August 14, 2019 | Wednesday | News
Samsung BioLogics implements N-1 perfusion for commercial application

Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...

August 13, 2019 | Tuesday | News
Gencurix reveals new study for early stage breast cancer

Gencurix, Inc., a Korea based company dedicated in development and market of innovative molecular diagnostics, has annou...

August 13, 2019 | Tuesday | News
South Korea’s pharma-biotech space to attract foreign investment

South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...

August 8, 2019 | Thursday | News
SillaJen to discontinue PHOCUS trial for advanced liver cancer

SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...

August 6, 2019 | Tuesday | News
Drive for generics sees Korea increasingly attractive to international pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceut...

August 2, 2019 | Friday | News
Samsung BioLogics, UCB sign third drug manufacturing deal

South Korea headquartered Samsung BioLogics (SBL) and Belgium based biopharmaceutical company UCB have agreed to an addi...

August 1, 2019 | Thursday | News
Mezzion Pharma announces positive results from FUEL trial

Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fonta...

July 31, 2019 | Wednesday | News
LISCure Biosciences completes seed funding of $5M

LISCure Biosciences, a South Korea based biotech company that researches and develops bacteria-mediated immunotherapy, h...

July 26, 2019 | Friday | News
FDA approves arthritis drug by Samsung Bioepis

Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing all three first-generatio...

July 24, 2019 | Wednesday | News
Shinsung TK paves way for IoT Healthcare in Asia

Shinsung TK, a Korean company specializing in security system based on IoT (Internet of Things) technology, has become v...

July 23, 2019 | Tuesday | News
Orum Therapeutics raises $30M to advance Ab technology

South Korea based Orum Therapeutics has announced an oversubscribed $30 million Series B financing. New investors, ...

July 22, 2019 | Monday | News
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equ...

July 18, 2019 | Thursday | News
Janssen Korea launches QuickFire Challenge in Smart Healthcare

Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, on 17 July 2019, announced the launch of the Seoul Innovati...

July 18, 2019 | Thursday | News
Bukwang Pharma subsidiary raises 3 billion won

Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A...

July 15, 2019 | Monday | News
Yuyu Pharma holds campaign for enhancing corporate transparency

Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management syst...

July 12, 2019 | Friday | News
Daewoong Pharmaceutical introduced the excellence of NABOTA® (Prabotulinumtoxin A)

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in ...

July 9, 2019 | Tuesday | News
Bridge Biotherapeutics becomes new resident at JLABS

Bridge Biotherapeutics, a South Kprea based clinical-stage biotech company, which aims to develop novel therapeutics for...

July 4, 2019 | Thursday | News
Boehringer Ingelheim inks $870M worth deal with Yuhan Corp

Boehringer Ingelheim and Yuhan Corporation have announced a collaboration and license agreement for the development of a...

July 3, 2019 | Wednesday | News
BNO BIO invests $1M in Israeli biotech firm

BNO BIO, a joint venture between South Korea based Bukwang Pharm and OCI, has invested in overseas biotech venture compa...

July 2, 2019 | Tuesday | News
World's first medical & donation coin disclosed on BW.com

SDCOIN, the world's first medical and donation coin, on 24 June 2019, in Seoul, South Korea, announced on BW.com, the gl...

June 25, 2019 | Tuesday | News
AstraZeneca signs LoI with Korea Biotech Industry Organisation

At the recently held Korea-Sweden Business Summit, pharmaceutical firm AstraZeneca signed a letter of intent (LoI) with ...

June 21, 2019 | Friday | News
Seegene establishes Brazilian subsidiary

Seegene Inc., a leading developer of multiplex PCR technologies based in South Korea, on 18 June 2019, has announced the...

June 19, 2019 | Wednesday | News
Y-Biologics, Dualogics to co-develop antibody against cancer

Y-Biologics, a South Korea based human antibody company, has signed an agreement with Dualogics, a dual antibody company...

June 17, 2019 | Monday | News
Macrogen signs subscription agreement of 4.1M AUD with Microba

Precision medicine and biotechnology company headquartered in Korea, Macrogen announced that the company signed a subscr...

June 14, 2019 | Friday | News
CytoDyn, Samsung BioLogics formalize manufacturing partnership

CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential f...

May 31, 2019 | Friday | News
Korean scientists 3D print artificial corneas

Professor Dong-Woo Cho of Mechanical Engineering, Professor Jinah Jang of Creative IT Convergence Engineering, and Ms. H...

May 30, 2019 | Thursday | News
Samsung Biologics to showcase end-to-end CDMO capabilities at BIO International 2019

For the eighth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full en...

May 29, 2019 | Wednesday | News
OliX Pharma expands ocular disease pipeline

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics in South Korea, announced an expansion of...

May 15, 2019 | Wednesday | News
MEDI FUTURES signs MOU with SUHB for clinical research

MEDI FUTURES, a South Korea based biomedical ultrasound company and a member company of the Born2Global Centre, sig...

May 6, 2019 | Monday | News
Samsung Biologics signs contract with GI Innovation

South Korea headquartered Samsung BioLogics and GI Innovation have signed a Contract Development Organization ...

May 6, 2019 | Monday | News
Macrogen, Exosome Plus to jointly develop exosome-based diagnostic & treatment solutions

The precision medicine and biotechnology company Macrogen has announced on April 24 that it had signed a supply con...

April 24, 2019 | Wednesday | News
Novotech strengthens South Korean clinical capabilities

Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has further strengthened its pr...

April 22, 2019 | Monday | News
Dr. Vavvas joins OliX Pharma’s Scientific Advisory Board

OliX Pharmaceuticals, a leading developer of RNAi therapeutics has announced that Demetrios G. Vavvas, M.D., Ph.D., one ...

April 22, 2019 | Monday | News
GC Pharma joins the Bleeding Disorder's Community to celebrate World Hemophilia Day

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company joins World Hemophilia D...

April 16, 2019 | Tuesday | News
Celltrion, iProgen Biotech to develop a series of novel ADCs

South Korea-based Celltrion and the Canada-based iProgen Biotech has announced to agree  to partner for the de...

April 9, 2019 | Tuesday | News
West Pharma expands APAC biz with new Korean office

West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, has expanded i...

April 5, 2019 | Friday | News
Standigm raises $11.5M in Series B Round

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...

April 2, 2019 | Tuesday | News
GCAM opens new plasma collection centre

GCAM, Inc., headquartered in Fullerton, CA, was established in 2009 and a member of South Korea's GC grou...

March 26, 2019 | Tuesday | News
LegoChem Biosciences, Takeda collaborate for immuno-oncology research

LegoChem Biosciences has announced that it has entered a research collaboration and license agreement with Takeda Pharma...

March 25, 2019 | Monday | News
PDC*line Pharma enters into a licensing agreement with LG Chem

PDC*line Pharma, a biotech company developing a new class of potent and scalable antigen presenting cell, based on a pro...

March 22, 2019 | Friday | News
Samsung BioLogics wins CMO leadership awards in six categories

Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based i...

March 22, 2019 | Friday | News
ACell enters distribution agreement for wound management

ACell, Inc. a leading regenerative medicine company, has recently announced that it has entered into an exclusive distri...

March 20, 2019 | Wednesday | News
Théa, OliX to develop RNAi therapies for AMD treatment

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and col...

March 18, 2019 | Monday | News
ResMed completes acquisition of HB Healthcare

ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has announced ...

March 14, 2019 | Thursday | News
Medical Korea 2019 to explore global healthcare era

The global healthcare and medical tourism conference "Medical Korea 2019" will be held for three days from March 14 at G...

March 6, 2019 | Wednesday | News
Can-Fite expands its Namodenoson Distribution Deal with CKD

Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...

February 27, 2019 | Wednesday | News
ABL Bio, WuXi Bio expand strategic collaboration for $220M

WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...

February 26, 2019 | Tuesday | News
Xynomic Pharma doses first South Korean patient in Phase 3 RCC trial

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp.jointly ...

February 25, 2019 | Monday | News
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study

Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...

February 22, 2019 | Friday | News
Korean govt to inject $2.6B to develop biotech in 2019

According to reports from the Korean Herald,  the government of Korea will spend 2.93 trillion won (US$2.61 billion...

February 20, 2019 | Wednesday | News
ROKIT brings innovative 3D bioprinting strategy for skin regeneration

ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic str...

February 20, 2019 | Wednesday | News
SK Biopharma to take antiepileptic drug to Europe

SK Biopharmaceuticals and Arvelle Therapeutics GmbH have announced that they have entered into an exclusive licensing ag...

February 18, 2019 | Monday | News
Bridge Bio presents Preclinical, Ph I study results for BBT-401

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the...

February 12, 2019 | Tuesday | News
OliX announces clinical candidate for Geographic Atrophy treatment

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...

January 29, 2019 | Tuesday | News
US FDA approves Samsung Bioepis' first oncology drug

Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencin...

January 21, 2019 | Monday | News
Bridge Bio receives FDA ODD for IPF drug

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...

January 17, 2019 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls